Aarey Drugs (India) Buy Hold or Sell Recommendation
| AAREYDRUGS | 56.29 1.60 2.93% |
Assuming the 90 days trading horizon and your slightly conservative level of risk, our recommendation regarding Aarey Drugs Pharmaceuticals is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Aarey Drugs Pharmaceuticals given historical horizon and risk tolerance towards Aarey Drugs. When Macroaxis issues a 'buy' or 'sell' recommendation for Aarey Drugs Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Aarey Drugs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Aarey and provide practical buy, sell, or hold advice based on investors' constraints. Aarey Drugs Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Aarey |
Execute Aarey Drugs Buy or Sell Advice
The Aarey recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aarey Drugs Pharmaceuticals. Macroaxis does not own or have any residual interests in Aarey Drugs Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aarey Drugs' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Aarey Drugs Trading Alerts and Improvement Suggestions
| Aarey Drugs Pharmace generated a negative expected return over the last 90 days | |
| Aarey Drugs generates negative cash flow from operations | |
| About 51.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Aarey Drugs Pharmaceuticals standalone net profit rises 30.08 percent in the September 2024 quarter - Business Standard |
Aarey Drugs Returns Distribution Density
The distribution of Aarey Drugs' historical returns is an attempt to chart the uncertainty of Aarey Drugs' future price movements. The chart of the probability distribution of Aarey Drugs daily returns describes the distribution of returns around its average expected value. We use Aarey Drugs Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aarey Drugs returns is essential to provide solid investment advice for Aarey Drugs.
| Mean Return | -0.12 | Value At Risk | -3.85 | Potential Upside | 4.99 | Standard Deviation | 2.86 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aarey Drugs historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aarey Drugs Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 42.5M | (14.6M) | 47.8M | (151.4M) | (58.6M) | (55.6M) | |
| Change In Cash | 1.3M | 1.5M | (4.6M) | 5.1M | 8.9M | 9.3M | |
| Free Cash Flow | 19.4M | 26.0M | (66.9M) | (23.3M) | (33.0M) | (34.7M) | |
| Depreciation | 8.9M | 9.2M | 19.9M | 15.7M | 17.0M | 9.9M | |
| Other Non Cash Items | 2.8M | 7.7M | (15.9M) | 5.9M | 30.4M | 32.0M | |
| Capital Expenditures | 9.2M | 28.8M | 22.0M | 10.4M | 7.2M | 6.9M | |
| Net Income | 72.4M | 83.0M | 100.3M | 60.2M | 46.8M | 47.9M | |
| End Period Cash Flow | 5.0M | 6.5M | 1.9M | 7.1M | 15.9M | 9.4M | |
| Investments | (9.2M) | (28.8M) | (22.0M) | 4.4M | (17.0M) | (17.9M) | |
| Change To Netincome | 24.2M | 17.3M | 25.5M | 18.9M | 21.8M | 21.8M |
Aarey Drugs Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aarey Drugs or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aarey Drugs' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aarey stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.17 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 2.86 | |
Ir | Information ratio | -0.08 |
Aarey Drugs Volatility Alert
Aarey Drugs Pharmaceuticals exhibits very low volatility with skewness of 1.11 and kurtosis of 2.03. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aarey Drugs' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aarey Drugs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Aarey Drugs Fundamentals Vs Peers
Comparing Aarey Drugs' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aarey Drugs' direct or indirect competition across all of the common fundamentals between Aarey Drugs and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aarey Drugs or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aarey Drugs' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aarey Drugs by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aarey Drugs to competition |
| Fundamentals | Aarey Drugs | Peer Average |
| Return On Equity | 0.0374 | -0.31 |
| Return On Asset | 0.0058 | -0.14 |
| Profit Margin | 0.01 % | (1.27) % |
| Operating Margin | 0.01 % | (5.51) % |
| Current Valuation | 1.85 B | 16.62 B |
| Shares Outstanding | 28.35 M | 571.82 M |
| Shares Owned By Insiders | 51.13 % | 10.09 % |
| Shares Owned By Institutions | 2.62 % | 39.21 % |
| Price To Book | 1.17 X | 9.51 X |
| Price To Sales | 0.34 X | 11.42 X |
| Revenue | 3.96 B | 9.43 B |
| Gross Profit | 207.6 M | 27.38 B |
| EBITDA | 45.16 M | 3.9 B |
| Net Income | 46.84 M | 570.98 M |
| Total Debt | 313.52 M | 5.32 B |
| Book Value Per Share | 47.33 X | 1.93 K |
| Cash Flow From Operations | (25.8 M) | 971.22 M |
| Earnings Per Share | 2.00 X | 3.12 X |
| Beta | 0.92 | -0.15 |
| Market Capitalization | 1.59 B | 19.03 B |
| Total Asset | 3.03 B | 29.47 B |
| Retained Earnings | 531.26 M | 9.33 B |
| Working Capital | 1.14 B | 1.48 B |
| Net Asset | 3.03 B |
Aarey Drugs Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aarey . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Aarey Drugs Buy or Sell Advice
When is the right time to buy or sell Aarey Drugs Pharmaceuticals? Buying financial instruments such as Aarey Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aarey Drugs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Momentum Thematic Idea Now
Momentum
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.